4.7 Article

Crystal structure of a soluble fragment of poliovirus 2CATPase

期刊

PLOS PATHOGENS
卷 14, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1007304

关键词

-

资金

  1. National Key Research and Development Program of China [2016YFD0500300]
  2. National Natural Science Foundation of China [81772207, 81572005]
  3. CAMS Innovation Fund for Medical Sciences [2017-I2M-1-014]

向作者/读者索取更多资源

Poliovirus (PV) 2C(ATPase) is the most studied 2C protein in the Picornaviridae family. It is involved in RNA replication, encapsidation and uncoating and many inhibitors have been found that target PV 2C(ATPase). Despite numerous investigations to characterize its functions, a high-resolution structure of PV 2C has not yet been determined. We report here the crystal structure of a soluble fragment of PV 2C(ATPase) to 2.55 angstrom, containing an ATPase domain, a zinc finger and a C-terminal helical domain but missing the N-terminal domain. The ATPase domain shares the common structural features with EV71 2C and other Superfamily 3 helicases. The C-terminal cysteine-rich motif folds into a CCCC type zinc finger in which four cysteine ligands and several auxiliary residues assist in zinc binding. By comparing with the known zinc finger fold groups, we found the zinc finger of 2C proteins belong to a new fold group, which we denote the Enterovirus 2C-like group. The C-terminus of PV 2C(ATPase) forms an amphipathic helix that occupies a hydrophobic pocket located on an adjacent PV 2C(ATPase) in the crystal lattice. The C-terminus mediated PV 2C-2C interaction promotes self-oligomerization, most likely hexamerization, which is fundamental to the ATPase activity of 2C. The zinc finger is the most structurally diverse feature in 2C proteins. Available structural and virological data suggest that the zinc finger of 2C might confer the specificity of interaction with other proteins. We built a hexameric ring model of PV 2C(ATPase) and visualized the previously identified functional motifs and drug-resistant sites, thus providing a structure framework for antiviral drug development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据